The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Oxaliplatin plus capecitabine (XELOX) in the perioperative treatment of locally advanced gastric adenocarcinoma in combination with D2 gastrectomy (NEO-CLASSIC).
 
Tianshu Liu
Honoraria - Bayer; Merck; Merck Serono; Roche; Thallion Pharmaceuticals
Consulting or Advisory Role - Merck Serono; Roche
Speakers' Bureau - Bayer; Merck Serono; Pfizer; Roche
Research Funding - Bayer; Merck; Merck Serono; Roche; Sanofi
 
Yiyi Yu
Consulting or Advisory Role - GlaxoSmithKline (Inst); Hengrui Pharmaceutical; Merck; Merck Serono; Pfizer; Roche; Sanofi; Taiho Pharmaceutical
Speakers' Bureau - Chia Tai Tianqing Pharmaceutical Group; GlaxoSmithKline; Jiangsu Hengrui Medicine; Merck; Merck KGaA; Merck Serono; Pfizer; Roche; Sanofi
Research Funding - Roche
 
Yong Fang
No Relationships to Disclose
 
Zhenbin Shen
Speakers' Bureau - Roche; Sanofi
 
Min Yan
Speakers' Bureau - Bayer; Bayer; Bayer; Merck; Merck; Merck; Merck Serono; Merck Serono; Merck Serono; Roche; Roche; Roche; Sanofi; Sanofi; Sanofi
 
Hui Cao
Speakers' Bureau - Merck; Roche
 
Yingbin Liu
Speakers' Bureau - Merck; Merck Serono; Roche; Sanofi
 
Xuefei Wang
No Relationships to Disclose
 
Yuehong Cui
Speakers' Bureau - Merck; Merck Serono; Roche; Sanofi
 
Yan Wang
No Relationships to Disclose
 
Fenlin Liu
No Relationships to Disclose
 
Weidong Chen
No Relationships to Disclose
 
Wei Li
No Relationships to Disclose
 
Yihong Sun
Speakers' Bureau - Roche; Sanofi
Research Funding - Roche